A/H1N1 flu: Policy on antiviral drugs needs to be revised ...

BMJ (Online)

Volumn 339, Issue 7712, 2009, Pages 63-

  English, Peter M ^a   Carroll, Kevin ^b   Majeed, Azeem ^c   Sundkvist, Torbjorn ^b   Millership, Sally ^d   Chambers, Sharon ^e  

^a c/o Dorset House   (United Kingdom)

^b Imperial College London ^*

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Public Health Medicine Environment Group   (United Kingdom)

^e Microbiology Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; SIALIDASE INHIBITOR;

CLINICAL FEATURE; DRUG USE; FEVER; FLU LIKE SYNDROME; HEALTH CARE POLICY; HUMAN; INFECTION RISK; INFLUENZA; LETTER; PRIORITY JOURNAL; SWINE INFLUENZA; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT; INFLUENZA VIRUS A H1N1;

ANTIVIRAL AGENTS; GREAT BRITAIN; HEALTH POLICY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN;

EID: 68149142495     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2728     Document Type: Letter

References (4)

1. Health Protection Agency, NHS London. HPA and NHS London Algorithm. Available at: www.lmc.org.uk/uploads/files/news/2009/ londonswinefluhpaalgorithmjun09.pdf, .
2. Rapid responses to O'Dowd A. UK scientific adviser criticises UK planning for flu pandemic. BMJ 2009;338:b2316. (9 June.) http://www.bmj.com/cgi/ eletters/338/jun09-1/b2316, .[CrossRef]
3. Roxon N. New Pandemic Phase PROTECT. Canberra: Department of Health and Ageing, 2009. Available at: www.health.gov.au/internet/ministers/publishing.nsf/ Content/mr-yr09-nr-nr082.htm, .
4. Jefferson TO, Demicheli V, Di Pietrantonj C, Jones M, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Systematic Reviews 2006;3(3):CD001265. www.cochrane.org/news/articles/CD001265-standard.pdf, .